Skip to main content
This site is intended for UK based practising healthcare professionals only.
Latest News:
  • Announcing our next event, a PCWHS webinar: From guidance to practice: What’s new in the UKMEC for contraception. Registrations now open here: Explore the Event
  • Interested in setting up a women’s health hub and grow it into an integral women’s health service? Use our essential Women's Health Hub toolkit to get you started
  • Become a member and have access to exclusive resources – guidelines, webinars, podcasts, and event recordings
Read further
Member Login Join Now Contact Search
×
Resources

Genitourinary syndrome of the menopause (GSM)

Author: Dr Kirsty Gillies

Format: Further Reading Source: PCWHS document


Many women notice changes in their vagina, vulva and bladder (the urogenital area) during and after the menopause. Vulvovaginal atrophy (VVA, also known as urogenital atrophy or genitourinary syndrome of menopause (GSM)) is a common and under-reported menopausal condition arising from decreased oestrogenisation of the vaginal tissue.

The comparison table in this resource has been created by consensus by the PCWHS. It compares the different types of treatment for VVA, including useful expert notes agreed by GPs and menopause specialists working in primary care.

This resource provides useful advice on treatment options and support.

This resource has been produced on behalf of the PCWHS. It is for guidance only; healthcare professionals should use their own judgment when applying it to patient care.

 

Search Resources